ghk-cu fda is ghk cu approved injectable adds non-injectable back to Category 1. FDA Everything You Need to Know

According to Prdrag et al

Manufacturing of this sterile product demands proper aseptic environment, well-functioned machines and compliance to good manufacturing practices to attain a high quality product

While this effect is minor in a sealed vial over the short term, refrigeration helps keep the preservative where it belongs: in the solution

References Frontiers in Endocrinology (2021) Progress on the Function and Application of Thymosin 4 Annals of the New York Academy of Sciences Thymosin 4: roles in development, repair, and engineering of the cardiovascular system Frontiers in Pharmacology (2022) Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 HSS Journal (2025) Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Current Pharmaceutical Design (2018) Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract Journal of Orthopaedic Surgery and Research (2019) BPC 157 and its effects on tendon healing CDC (2024) Vaccine Administration: Subcutaneous (SUBCUT) Injection NCBI Bookshelf (2023) Administration of Parenteral Medications Nursing Skills CDC (NCHS) Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) Additional Research and Background These sources provide related context and are not presented as support for a specific statement above